IHS Chemical Week

People & Business :: Companies

Mylan to Acquire Remaining Stake in Indian API Subsidiary for $133 million

3:50 AM MDT | March 27, 2009 | Deepti Ramesh

Mylan (Canonsburg, PA) says it plans to purchase the remaining interest in its Matrix Laboratories (Secunderabad, India) subsidiary from minority shareholders for a total of about $133 million, and also delist Matrix from the Indian stock exchanges. Mylan currently owns 71.2% of Matrix. Matrix manufactures active pharmaceutical ingredients (APIs) and finished dosage forms, and it will be delisted from the Bombay Stock Exchange, and the National Stock Exchange of India. “Purchasing the remaining interest in Matrix and delisting it from the exchanges will...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa